Foghorn Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 4.74 USD | 6,95 USD | 3,27 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 11,444 USD | 5 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 58.713.922 | 4,8 | 4,02 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Foghorn Therapeutics Inc
Mitarbeiter 106
Handelsplatz NASDAQ
Ticker Symbol FHTX
IPO Datum 2020-10-23
Adresse 99 Coolidge Avenue, Watertown, MA, United States, 02472
Webseite https://foghorntx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Douglas G. Cole M.D. | Founder & Independent Chairman of the Board |
| 2 | Mr. Adrian H. B. Gottschalk | President, CEO & Director |
| 3 | Dr. Steven F. Bellon Ph.D. | Chief Scientific Officer |
| 4 | Dr. Alfonso Quintas Cardama M.D. | Chief Medical Officer |
| 5 | Dr. Gerald R. Crabtree M.d. | Founder & Member of Scientific Advisory Board |
| 6 | Mr. Ryan D. Maynard | Chief Financial Officer |
| 7 | Ms. Karin Hellsvik | Chief of Staff to the CEO, VP, Head of Corporate Affairs, Investor Relations & Operations |
| 8 | Mr. Michael J. LaCascia J.D. | Chief Legal Officer |
| 9 | Mr. Saurabh Sewak Ph.D. | Vice President of Corporate Development |
| 10 | Mr. Carlos Costa | Chief People Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Flagship Ventures Management, Inc. | 0,00% | 0,00 Mio. USD |
| 2 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 3 | Bvf Inc | 0,00% | 0,00 Mio. USD |
| 4 | Deerfield Management Co | 0,00% | 0,00 Mio. USD |
| 5 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 7 | Euclidean Capital LLC | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Siren, L.L.C. | 0,00% | 0,00 Mio. USD |
| 11 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 12 | Ameriprise Financial Inc | 0,00% | 0,00 Mio. USD |
| 13 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 14 | Candriam Luxembourg S.C.A. | 0,00% | 0,00 Mio. USD |
| 15 | Jacobs Levy Equity Management, Inc. | 0,00% | 0,00 Mio. USD |
| 16 | Birchview Capital, LP | 0,00% | 0,00 Mio. USD |
| 17 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 18 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Vanguard Fiduciary Trust Co | 0,00% | 0,00 Mio. USD |
| 20 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |